In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 6, 2005, Pages 2507-2509

  Giacometti, Andrea ^a,c   Cirioni, Oscar ^a   Kamysz, Wojciech ^b   Silvestri, Carmela ^a   Del Prete, Maria Simona ^a   Licci, Alberto ^a   D'Amato, Giuseppina ^a   Łukasiak, Jerzy ^b   Scalise, Giorgio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c Ospedale Regionale Torrette   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CITROPIN 1 1; CLARITHROMYCIN; DOXYCYCLINE; LINEZOLID; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL SKIN DISEASE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENTEROCOCCUS FAECALIS; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; TIME SERIES ANALYSIS;

AMPHIBIAN PROTEINS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; COLONY COUNT, MICROBIAL; DRUG INTERACTIONS; DRUG RESISTANCE, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; GRAM-POSITIVE COCCI; HUMANS; MICROBIAL SENSITIVITY TESTS; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS;

EID: 19544367415     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.6.2507-2509.2005     Document Type: Article

References (19)

1. Arbeit, R. D., D. Maki, F. P. Tally, E. Campanaro, B. I. Eisenstein, and the daptomycin 98-01 and 99-01 Investigator. 2004. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin. Infect. Dis. 38:1673-1681.
2. Bevins, C. L., and M. Zasloff. 1990. Peptides from frog skin. Annu. Rev. Biochem. 59:395-414.
3. Bisno, A. L., and D. L. Stevens. 1996. Streptococcal infections of skin and soft tissues. N. Engl. J. Med. 334:240-245.
4. Cannon, M. 1987. A family of wound healers. Nature 328:478.
5. Cormican, M. G., and R. N. Jones. 1996. Emerging resistance to antimicrobial agents in Gram-positive bacteria. Enterococci, staphylococci and non-pneumococcal streptococci. Drugs 51:S6-S12.
6. DiNubile, M. J., and B. A. Lipsky. 2004. Complicated infections of skin and structures: when the infection is more than skin deep. J. Antimicrob. Chemother. 53(Suppl. 2):ii37-ii50.
7. Doyle, J., C. S. Brinkworth, K. L. Wegener, J. A. Carver, L. E. Llewellin, I. N. Olver, J. H. Bowie, P. A. Wabnitz, and M. J. Tyler. 2003. nNOS inhibition, antyimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications. The solution structure of a modified citropin 1.1. Eur. J. Biochem. 270:1141-1153.
8. Eliopoulos, G. M., and R. C. Moellering, Jr. 1996. Antimicrobial combinations, p. 330-393. In V. Lorian (ed.), Antibiotics in laboratory medicine. Williams & Wilkins, Baltimore, Md.
9. Elston, D. M. 2004. Epidemiology and prevention of skin and soft tissue infections. Cutis 73:S3-S7.
10. Fields, G. B., and R. L. Noble. 1990. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Peptide Protein Res. 35: 161-214.
11. Hancock, R. E. W. 2001. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 1:156-164.
12. Hancock, R. E. W., and D. S. Chapple. 1999. Peptide antibiotics. Antimicrob. Agents Chemother. 43:1317-1323.
13. Kahn, R. M., and E. J. C. Goldstein. 1993. Common bacterial skin infections: diagnostic clues and therapeutic options. Postgrad. Med. 93:175-182.
14. Linden, P. K. 2002. Treatment options for vancomycin-resistant enterococcal infections. Drugs 62:425-441.
15. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. National Committee for Clinical Laboratory Standards, Villanova, Pa.
16. Raghavan, M., and P. K. Linden. 2004. Newer treatment options for skin and soft tissue infections. Drugs 64:1621-1642.
17. Tenover, F. C., J. W. Biddle, and M. V. Lancaster. 2001. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus Emerg. Infect. Dis. 7:327-332.
18. Vaara, M., and M. Porro. 1996. Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria. Antimicrob. Agents Chemother. 40:1801-1805.
19. Wabnitz, P. A., J. H. Bowie, J. C. Wallace, and M. J. Tyler. 1999. The antibiotic citropin peptides from the Australian tre frog Litoria citropa. Structure determination using electrospray mass spectrometry. Rapid Commun. Mass Spectrom. 13:1724-1732.